Rasmus Holm-Jorgensen
Directeur Financier/CFO chez ACRIVON THERAPEUTICS, INC.
Fortune : 158 096 $ au 30/06/2024
Provenance du réseau au premier degré de Rasmus Holm-Jorgensen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 31 | |
Extinct | Biotechnology | 27 | |
Public Company | Pharmaceuticals: Major | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rasmus Holm-Jorgensen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Chief Operating Officer Corporate Officer/Principal | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Medical Specialties | Director/Board Member Director/Board Member | |
Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Suffolk University | College/University | Director/Board Member Graduate Degree | |
University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
D'Amore-Mckim School of Business | College/University | Masters Business Admin Masters Business Admin | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Compliance Officer | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Boston College Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Wallace E Carroll School of Management | College/University | Masters Business Admin Masters Business Admin | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Director of Finance/CFO | |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genomic Life, Inc.
Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
ZAI LAB LIMITED | Biotechnology | Director/Board Member Corporate Officer/Principal | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel | |
KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistiques
Internationale
Etats-Unis | 44 |
Royaume-Uni | 3 |
Danemark | 2 |
Chine | 2 |
Îles Cayman | 2 |
Sectorielle
Health Technology | 33 |
Consumer Services | 12 |
Health Services | 3 |
Commercial Services | 3 |
Finance | 2 |
Opérationnelle
Director/Board Member | 230 |
Corporate Officer/Principal | 122 |
Independent Dir/Board Member | 93 |
Undergraduate Degree | 48 |
Chief Tech/Sci/R&D Officer | 34 |
Relations les plus connectées
Insiders | |
---|---|
Felix Baker | 29 |
Thomas Tisch | 27 |
Kim Popovits | 20 |
Ivana Magovcevic-Liebisch | 18 |
Thomas Malley | 18 |
J. Goater | 17 |
Derek DiRocco | 17 |
Richard Levy | 17 |
Mark Goldberg | 17 |
Carsten Boess | 15 |
Peter Wirth | 15 |
Barry Quart | 14 |
Matthew Osborne | 14 |
Stephen Biggar | 13 |
Charles Baum | 12 |
- Bourse
- Insiders
- Rasmus Holm-Jorgensen
- Connexions Sociétés